{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:08:04Z","timestamp":1785769684476,"version":"3.56.0"},"reference-count":43,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Infection"],"published-print":{"date-parts":[[2026,8]]},"abstract":"\n Background:<\/jats:title>\n In 2016, Uganda adopted the WHO HIV drug resistance (HIVDR) monitoring strategy to track treatment outcomes following the introduction of a dolutegravir (DTG) based regimen as first line among people living with HIV (PLHIV). However, despite widespread transition to DTG-based regimens, evidence on acquired DTG resistance and its determinants remains limited.<\/jats:p>\n <\/jats:sec>\n \n Objectives:<\/jats:title>\n To determine the prevalence of acquired DTG resistance among PLHIV with virologic failure and identify associated factors in North-Eastern Uganda.<\/jats:p>\n <\/jats:sec>\n \n Design:<\/jats:title>\n We conducted a retrospective cross-sectional study from 24 accredited antiretroviral therapy health facilities in North-Eastern Uganda by 28th February 2025.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n The study included eligible PLHIV on DTG-based regimens with at least 2 viral loads >1000 copies\/mL and a documented HIV genotypic resistance testing result between April 2022 and July 2024. Clinical data were extracted from the national drug resistance dashboard and verified against facility electronic medical records. Logistic regression via generalised estimating equations (GEE) was used to identify factors associated with DTG resistance. A\n p<\/jats:italic>\n -value\u2009<\u20090.05 was considered statistically significant.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Of 225 participants, the median age was 19\u2009years (interquartile range: 15\u201339), and 55.1% (\n n<\/jats:italic>\n \u2009=\u2009124) were male. The prevalence of high-level to intermediate DTG resistance was 18.7% (\n n<\/jats:italic>\n \u2009=\u200942), with 14.2% (\n n<\/jats:italic>\n \u2009=\u200932) having high-level resistance to DTG and 4.4% (\n n<\/jats:italic>\n \u2009=\u200910) intermediate resistance. Most participants were unemployed (60.0%,\n n<\/jats:italic>\n \u2009=\u2009135) and had not disclosed their HIV status (74.2%,\n n<\/jats:italic>\n \u2009=\u2009167). DTG resistance was associated with presence of nucleoside reverse transcriptase inhibitor (NRTI) drug resistance mutations (DRMs) (adjusted odds ratio (aOR); 12.14, 95% confidence interval (CI): 4.14\u201335.65,\n p<\/jats:italic>\n \u2009<\u20090.001), poor adherence (aOR; 6.19, 95% CI: 2.54\u201315.11,\n p<\/jats:italic>\n \u2009=\u20090.001), DTG use\u2009\u2a7e\u20093\u2009years (aOR; 9.19, 95% CI: 1.60\u201352.74,\n p<\/jats:italic>\n \u2009=\u20090.013), and alcohol\/substance abuse (aOR; 3.94, 95% CI: 1.74\u20138.91,\n p<\/jats:italic>\n \u2009=\u20090.001).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Nearly one in five PLHIV with virologic failure exhibited DTG resistance, predominantly high-level. Key associated factors included poor adherence, being on DTG for \u2a7e3\u2009years, alcohol\/substance abuse, and the presence of relevant NRTI DRM. Strengthening family and peer support, integrating substance abuse screening and management in HIV care, and improving adherence may help reduce the risk of DTG resistance. These findings highlight the urgent need for enhanced HIVDR monitoring and tailored interventions to sustain progress toward HIV epidemic control by 2030.<\/jats:p>\n <\/jats:sec>","DOI":"10.1177\/20499361261467152","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:29:05Z","timestamp":1785583745000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and determinants of dolutegravir resistance among people living with HIV with virologic failure in North-Eastern Uganda: a retrospective cross-sectional study (2022\u20132024)"],"prefix":"10.1177","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-6270-4953","authenticated-orcid":false,"given":"Saadick","family":"Mugerwa Ssentongo","sequence":"first","affiliation":[{"name":"AIDS Information Centre (AIC), Directorate of Program Management and Capacity Development, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidah","family":"Kakooza Mulungi","sequence":"additional","affiliation":[{"name":"Mbarara National Referral Hospital, Ministry of Health, Mbarara City, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Opito","sequence":"additional","affiliation":[{"name":"AIDS Information Centre (AIC), Directorate of Program Management and Capacity Development, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Okello","sequence":"additional","affiliation":[{"name":"AIDS Information Centre (AIC), Directorate of Program Management and Capacity Development, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Nait","sequence":"additional","affiliation":[{"name":"AIDS Information Centre (AIC), Directorate of Program Management and Capacity Development, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Katende","sequence":"additional","affiliation":[{"name":"Soroti Regional Referral Hospital, Ministry of Health, Soroti City, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baker","family":"Bakashaba","sequence":"additional","affiliation":[{"name":"AIDS Information Centre (AIC), Directorate of Program Management and Capacity Development, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonniface","family":"Oryokot","sequence":"additional","affiliation":[{"name":"AIDS Information Centre (AIC), Directorate of Program Management and Capacity Development, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30093-6"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/OFID\/OFAF270"},{"key":"e_1_3_4_4_2","unstructured":"Eastern and Southern Africa\u2014Regional profile\u2014 2025 Global AIDS Update\u2014AIDS Crisis and the Power to Transform|UNAIDS https:\/\/www.unaids.org\/en\/resources\/documents\/2025\/2025-global-aids-update-esa (accessed 16 September 2025)."},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00051-6"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12040915"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa202"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003600"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000004007"},{"key":"e_1_3_4_10_2","unstructured":"World Health Organization (WHO). New report documents increase in HIV drug resistance to dolutegravir https:\/\/www.who.int\/news\/item\/05-03-2024-new-report-documents-increase-in-hiv-drug-resistance-to-dolutegravir (2024 accessed 2 May 2026)."},{"key":"e_1_3_4_11_2","unstructured":"UNAIDS. Uganda|UNAIDS https:\/\/www.unaids.org\/en\/regionscountries\/countries\/uganda (2025 accessed 16 September 2025)."},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf180"},{"key":"e_1_3_4_13_2","unstructured":"UPHIA. Uganda Summary Sheet 2020-2021 - PHIA Project https:\/\/phia.icap.columbia.edu\/uganda-summary-sheet-2020-2021\/ (2022 accessed 31 May 2024)."},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0331835"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.4103\/sja.SJA_543_18"},{"key":"e_1_3_4_16_2","article-title":"National Population and Housing Census 2024 Final Report Volume 1 (Main)","author":"Uganda Bureau of Statistics (UBOS)","year":"2024","unstructured":"Uganda Bureau of Statistics (UBOS). National Population and Housing Census 2024 Final Report Volume 1 (Main). Kampala: Republic of Uganda, 2024.","journal-title":"Kampala: Republic of Uganda"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad010"},{"key":"e_1_3_4_18_2","unstructured":"Stanford University. Release Notes - HIV Drug Resistance Database https:\/\/hivdb.stanford.edu\/page\/release-notes\/#drm.classification (2026 accessed 14 April 2026)."},{"key":"e_1_3_4_19_2","unstructured":"Swinkels HM Nguyen AD Samandari T et al. HIV and AIDS. In: StatPearls [Internet]. Treasure Island FL: StatPearls Publishing https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534860\/ (2026 accessed 28 January 2026)."},{"key":"e_1_3_4_20_2","unstructured":"Mets-programme. ART Card|UgandaEMR User Manual https:\/\/mets-programme.gitbook.io\/ugandaemr-documentation\/data_entry\/art_card (2016 accessed 28 January 2026)."},{"key":"e_1_3_4_21_2","unstructured":"STATA. Stata|StataCorp LLC https:\/\/www.stata.com\/company\/ (2024 accessed 10 November 2024)."},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/DIAGNOSTICS12112851"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(23)00228-X"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(24)00553-9"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae185"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(25)00127-4"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318189a753"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2021.100029"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3844\/ajidsp.2007.240.247"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.4102\/SAFP.V65I1.5660"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-012-0319-6"},{"key":"e_1_3_4_32_2","article-title":"Association of ART non-adherence with self-reported behavior and lifestyle among injecting drug users in the coastal region of Kenya","volume":"20","author":"Ng\u2019ong\u2019a GO","year":"2023","unstructured":"Ng\u2019ong\u2019a GO, Lwembe RM, Knight V, et al. Association of ART non-adherence with self-reported behavior and lifestyle among injecting drug users in the coastal region of Kenya. Sci Afr 2023; 20: e01598.","journal-title":"Sci Afr"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-011-0093-5"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-018-0636-7"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-47795-1"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1051096"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1617795"},{"key":"e_1_3_4_38_2","first-page":"1","article-title":"Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review","volume":"20","author":"SeyedAlinaghi SA","year":"2023","unstructured":"SeyedAlinaghi SA, Afsahi AM, Moradi A, et al. Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review. AIDS Res Therap 2023; 20: 1\u201322.","journal-title":"AIDS Res Therap"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832ba8ec"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389200224666230418093139"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08288-8"},{"key":"e_1_3_4_42_2","first-page":"1","article-title":"Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options","volume":"22","author":"Fokam J","year":"2025","unstructured":"Fokam J, Anim-Keng TT, Pokam BT, et al. Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options. AIDS Res Therap 2025; 22: 1\u20139.","journal-title":"AIDS Res Therap"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-00875-x"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11639-2"}],"container-title":["Therapeutic Advances in Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20499361261467152","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20499361261467152","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20499361261467152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:19:01Z","timestamp":1785766741000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20499361261467152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["10.1177\/20499361261467152"],"URL":"https:\/\/doi.org\/10.1177\/20499361261467152","relation":{},"ISSN":["2049-9361","2049-937X"],"issn-type":[{"value":"2049-9361","type":"print"},{"value":"2049-937X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"20499361261467152"}}